Graphique du cours de l'action ARGX
ARGX Gagner
argenx SE
$782.17
-0.65%
$-5.13
À la fermeture : May 08, 16:00:00 GMT-4
$790
1%
$7.83
Post-Marché: May 08, 20:00:00 GMT-4
Retour
argenx SE (ARGX) Gagner
Statistiques clés
Clôture préc.
$787.31
Prix d'ouverture
$787.08
Plage de la journée
$778.71 - $792
Plage de 52 semaines
$510.05 - $934.62
Volume
345.9K
Volume moyen
345.7K
Rendement en dividend
--
BPA (TTM)
19.61
Capitalisation boursière
$49.1B
Qu’est-ce que argenx SE ?
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. The company is headquartered in Amsterdam, Noord-Holland. The company went IPO on 2014-07-10. The company is primarily engaged in creating and developing a pipeline of differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The firm develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. The company includes, but is not limited to: Empasiprubart, a complement inhibitor targeting C2, blocking the function of both the classical and lectin pathways, while leaving the alternative pathway intact, ARGX-119 an antagonist to the MuSK receptor with potential in multiple neuromuscular indications.
Fonctionnalités
© 2026 Edgen fonctionné par